Apple announced that the current CEO of Johnson & Johnson, Alex Gorsky, will join its board of directors. Gorsky’s move, who will step down from his current position next January, to Apple’s executive team comes at a time when the company is also focusing on health and how it can make data more accessible to users and their customers. doctors.
Apple: Johnson & Johnson CEO joins Apple
In the press release announcing Gorsky’s role at Apple, Tim Cook defines him as “a visionary in the healthcare sector” with a great “passion for technology”. Apple for its part is focusing a lot on the health of users, just think of the Apple Watch, used mostly as a fitness device.
Recent updates of iOS e watchOS they brought new health features that make it easier to share medical records with doctors or family members. With Gorsky on the board, Apple could devise new features, or use its expertise to add further integrations with the medical establishment.
Moreover, Apple and Johnson & Johnson already have an established relationship: the two companies are working together on the Heartline study, designed to find out ifApple Watch it can help detect atrial fibrillation before symptoms become noticeable or dangerous.
However, Apple’s efforts for health have not been without controversy: some medical researchers have said that Apple’s lack of transparency in its algorithms for measure things like heart rate, makes it difficult to use Apple Watch data in search.
There have also been sources inside the company who have said that the healthcare division uses potentially misleading data to make product decisions, and that employees have also raised concerns about Apple’s plans for a trial in which it would act as a healthcare provider. principal. Gorsky’s assumptions should probably also be seen in this perspective.